Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Roche’s Avastin Gets FDA Approval In US
The US FDA has approved Roche’s Avastin (bevacizumab) plus interferon alpha for people with metastatic renal cell carcinoma, the most common type of kidney cancer. The FDA approval
The US FDA has approved Roche’s Avastin (bevacizumab) plus interferon alpha for people with metastatic renal cell carcinoma, the most common type of kidney cancer. The FDA approval
Access has released an update on its clinical development strategy for ProLindac, a novel DACH platinum drug that has shown to be active in many solid tumors in
Shire has reported positive results from the first of three phase III studies of velaglucerase alfa, its enzyme replacement therapy for the treatment of Type 1 Gaucher disease.
Cherokee has signed a new five-and-a-half-year commercial supply agreement with DuPont. Cherokee will manufacture a new product for DuPont using the latter’s proprietary fermentation process. Initial production is
Shin Nippon Biomedical Laboratories (SNBL) is developing an intranasal form of the antiemetic drug, granisetron (TRG) in the US. SNBL has announced the first report on the results
ProAssurance has reported an operating income of $50.4m, or $1.52 per diluted share for the second quarter of 2009, an increase when compare to $46.6m for the second
Zogenix and Astellas have entered into an exclusive co-promotion agreement for Sumavel DosePro (sumatriptan injection) needle-free delivery system. Sumavel DosePro, a needle-free delivery system for subcutaneous sumatriptan,
Teijin, a Japan-based specialty chemicals company, has posted net sale of ¥166 billion for the second quarter of 2009, a decrease of 29.8% as compared to ¥236 billion
Arkema has posted sales figures of E1.16 billion, as compared to E1.5 billion in the second quarter of 2008, a decline of 22.7%. EBITDA stood at E70 million,
The grant entails a collaborative effort between researchers at Micronics and the Seattle Children’s Research Institute (SCRI), in which a novel primer design method that enables detection of